tiprankstipranks
Advertisement
Advertisement

VTVT Stock Latest News

vTv Therapeutics: Buy Rating Reiterated on Favorable Risk-Reward and Clinical Momentum; $67 Price Target Unchanged
RatingsvTv Therapeutics: Buy Rating Reiterated on Favorable Risk-Reward and Clinical Momentum; $67 Price Target Unchanged
7d ago
VTVT
Analyst Maintains Buy on vTv Therapeutics, Reiterates Unchanged $49 Price Target Amid Progress of Cadisegliatin Program
PremiumRatings
Analyst Maintains Buy on vTv Therapeutics, Reiterates Unchanged $49 Price Target Amid Progress of Cadisegliatin Program
7d ago
VTVT
vTv Therapeutics Expands At-The-Market Share Program Capacity
PremiumCompany Announcements
vTv Therapeutics Expands At-The-Market Share Program Capacity
7d ago
8K
VTVT
vTv Therapeutics reports Q1 EPS $1.65, consensus 21c
PremiumThe Fly
vTv Therapeutics reports Q1 EPS $1.65, consensus 21c
7d ago
VTVT
vTv Therapeutics initiated with an Outperform at Evercore ISI
PremiumThe Fly
vTv Therapeutics initiated with an Outperform at Evercore ISI
2M ago
VTVT
vTv Therapeutics price target raised to $55 from $35 at Alliance Global
PremiumThe FlyvTv Therapeutics price target raised to $55 from $35 at Alliance Global
2M ago
VTVT
Buy Rating on vTv Therapeutics Underpinned by Late-Stage T1D Catalyst, Strengthened Balance Sheet, and Diversified Partnership-Driven Upside
Premium
Ratings
Buy Rating on vTv Therapeutics Underpinned by Late-Stage T1D Catalyst, Strengthened Balance Sheet, and Diversified Partnership-Driven Upside
2M ago
VTVT
vTv Therapeutics Highlights Cadisegliatin Phase 3 and Cash Runway
Premium
Company Announcements
vTv Therapeutics Highlights Cadisegliatin Phase 3 and Cash Runway
2M ago
8K
VTVT
vTv Therapeutics reports Q4 EPS (58c), consensus ($1.09)
PremiumThe Fly
vTv Therapeutics reports Q4 EPS (58c), consensus ($1.09)
2M ago
VTVT
vTv Therapeutics Highlights Cadisegliatin Progress and Financial Strength
PremiumCompany Announcements
vTv Therapeutics Highlights Cadisegliatin Progress and Financial Strength
3M ago
8K
VTVT
vTv Therapeutics Inc. (VTVT) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
vTv Therapeutics Inc. (VTVT) Q4 Earnings Cheat Sheet
3M ago
VTVT
vTv Therapeutics Expands Global HPP737 Rights with Newsoara
PremiumCompany Announcements
vTv Therapeutics Expands Global HPP737 Rights with Newsoara
4M ago
8K
VTVT
vTv Therapeutics expanded its license agreement with Newsoara Biopharma
PremiumThe FlyvTv Therapeutics expanded its license agreement with Newsoara Biopharma
4M ago
VTVT
vTv Therapeutics price target raised to $49 from $40 at BTIG
Premium
The Fly
vTv Therapeutics price target raised to $49 from $40 at BTIG
4M ago
VTVT
vTv Therapeutics initiated with a Buy at Roth Capital
Premium
The Fly
vTv Therapeutics initiated with a Buy at Roth Capital
4M ago
VTVT
vTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target
PremiumRatings
vTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target
4M ago
VTVT
vTv Therapeutics initiated with a Buy at TD Cowen
PremiumThe Fly
vTv Therapeutics initiated with a Buy at TD Cowen
5M ago
VTVT
Paradigm-Shifting Potential in Type 1 Diabetes: vTv Therapeutics’ Cadisegliatin Supports Buy Rating and Significant Upside
PremiumRatings
Paradigm-Shifting Potential in Type 1 Diabetes: vTv Therapeutics’ Cadisegliatin Supports Buy Rating and Significant Upside
5M ago
VTVT
vTv Therapeutics price target raised to $47 from $36 at H.C. Wainwright
PremiumThe Fly
vTv Therapeutics price target raised to $47 from $36 at H.C. Wainwright
5M ago
VTVT
vTv submits cadisegliatin study protocol to Department of Health Abu Dhabi
PremiumThe FlyvTv submits cadisegliatin study protocol to Department of Health Abu Dhabi
5M ago
VTVT
Positive Outlook for vTv Therapeutics: Buy Rating on Cadisegliatin’s Promising Phase 3 Trial and Market Potential
Premium
Ratings
Positive Outlook for vTv Therapeutics: Buy Rating on Cadisegliatin’s Promising Phase 3 Trial and Market Potential
6M ago
VTVT
vTv Therapeutics initiated with a Buy at BTIG
Premium
The Fly
vTv Therapeutics initiated with a Buy at BTIG
6M ago
VTVT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >